115 related articles for article (PubMed ID: 2993873)
21. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
22. Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect.
Depper JM; Bluestein HG; Zvaifler NJ
J Immunol; 1981 Nov; 127(5):1899-902. PubMed ID: 6271870
[TBL] [Abstract][Full Text] [Related]
23. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
Sun Q; Burton RL; Pollok KE; Emanuel DJ; Lucas KG
Cell Immunol; 1999 Aug; 195(2):81-8. PubMed ID: 10448007
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
25. Generation of large granular T lymphocytes in vivo during viral infection.
Biron CA; Natuk RJ; Welsh RM
J Immunol; 1986 Mar; 136(6):2280-6. PubMed ID: 3485144
[TBL] [Abstract][Full Text] [Related]
26. The effect of leucyl-leucine methyl ester on proliferation and Ig secretion of EBV-transformed human B lymphocytes.
Ohlin M; Danielsson L; Carlsson R; Borrebaeck CA
Immunology; 1989 Apr; 66(4):485-90. PubMed ID: 2541070
[TBL] [Abstract][Full Text] [Related]
27. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y
AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343
[TBL] [Abstract][Full Text] [Related]
28. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the in vitro outgrowth of Epstein-Barr virus-infected lymphocytes by TG lymphocytes.
Shope TC; Kaplan J
J Immunol; 1979 Nov; 123(5):2150-5. PubMed ID: 226628
[TBL] [Abstract][Full Text] [Related]
30. Phenotypes of human natural killer cell populations detected with monoclonal antibodies.
Zarling JM; Clouse KA; Biddison WE; Kung PC
J Immunol; 1981 Dec; 127(6):2575-80. PubMed ID: 7299137
[TBL] [Abstract][Full Text] [Related]
31. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells.
Le Gros GS; Herbert AG; Watson JD
Immunology; 1984 Jan; 51(1):103-13. PubMed ID: 6606615
[TBL] [Abstract][Full Text] [Related]
32. Tumor-activated NK cells trigger monocyte oxidative metabolism.
Pohajdak B; Gomez JL; Wilkins JA; Greenberg AH
J Immunol; 1984 Nov; 133(5):2430-6. PubMed ID: 6434630
[TBL] [Abstract][Full Text] [Related]
33. Depletion of NK cells with the lysosomotropic agent L-leucine methyl ester and the in vitro generation of NK activity from NK precursor cells.
Shau H; Golub SH
J Immunol; 1985 Feb; 134(2):1136-41. PubMed ID: 3871208
[TBL] [Abstract][Full Text] [Related]
34. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
35. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
36. A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8.
Perussia B; Fanning V; Trinchieri G
J Immunol; 1983 Jul; 131(1):223-31. PubMed ID: 6408172
[TBL] [Abstract][Full Text] [Related]
37. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
[TBL] [Abstract][Full Text] [Related]
38. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).
Abo T; Balch CM
J Immunol; 1981 Sep; 127(3):1024-9. PubMed ID: 6790607
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporin A renders target cells resistant to immune cytolysis.
Hudnall SD
Eur J Immunol; 1991 Jan; 21(1):221-6. PubMed ID: 1846819
[TBL] [Abstract][Full Text] [Related]
40. Imbalance of the Epstein-Barr virus-host relationship in AIDS-related complex patients.
Ragona G; Sirianni MC
Cancer Detect Prev Suppl; 1987; 1():549-52. PubMed ID: 2826004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
